Twist Bioscience CorporationTWSTNASDAQ

Revenue (LTM)

$377M

+20.3% YoY

Net Income (LTM)

$-78M

+62.8% YoY

Free Cash Flow

$-76M

Revenue CAGR (5Y)

+29.9%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	132	204↑53.8%	245↑20.4%	313↑27.7%	377↑20.3%
Gross Profit	52	84↑62.9%	90↑6.5%	133↑48.6%	191↑43.2%
Operating Income	-153	-235↓53.7%	-217↑7.5%	-221↓1.7%	-136↑38.3%
Net Income	-152	-218↓43.2%	-205↑6.1%	-209↓2.0%	-78↑62.8%
EBITDA	-144	-212↓47.1%	-174↑17.7%	-177↓1.5%	-52↑70.5%
EPS Diluted	-3.15	-4.04↓28.3%	-3.60↑10.9%	-3.60↓0.0%	-1.30↑63.9%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	466	379↓18.7%	286↓24.4%	226↓21.0%	183↓19.1%
Total Current Assets	546	596↑9.1%	424↓28.9%	347↓18.3%	333↓4.0%
Total Assets	702	961↑36.9%	776↓19.2%	614↓20.9%	642↑4.5%
Total Current Liabilities	63	91↑43.8%	73↓19.1%	71↓3.2%	91↑28.7%
Total Liabilities	121	172↑41.8%	153↓11.1%	142↓7.4%	169↑19.3%
Total Equity	581	789↑35.9%	623↓21.0%	473↓24.2%	473↑0.1%
Total Debt	63	95↑50.8%	94↓0.9%	85↓9.6%	137↑61.5%
Net Debt	-403	-284↑29.6%	-192↑32.2%	-141↑26.6%	-46↑67.6%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-112	-124↓10.8%	-142↓14.5%	-64↑55.0%	-48↑25.7%
Capital Expenditure	-27	-102↓276.4%	-28↑72.7%	-5↑81.7%	-28↓451.7%
Free Cash Flow	-139	-226↓62.4%	-170↑24.7%	-69↑59.4%	-76↓9.3%
Stock-Based Comp	37	80↑115.3%	30↓62.0%	51↑68.2%	64↑26.6%
Net Change in Cash	373	-87↓123.3%	-91↓4.5%	-60↑33.9%	-43↑28.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance